Literature DB >> 11790530

Trafficking of MHC class II molecules in the late secretory pathway.

Elizabeth M Hiltbold1, Paul A Roche.   

Abstract

Antigen presenting cells (APCs) alert the immune system to attack by extracellular organisms; APCs achieve this via internalization, degradation, and display of antigenic fragments on the cell surface by MHC class II molecules. These class II molecules bind to an accessory protein, termed the invariant chain, that ensures proper folding of the molecules. Invariant-chain binding also directs class II molecules to lysosomes, which are probably the most important sites for antigen loading. Endosomes are intermediates in the transport of class-II-invariant chain complexes to antigen-processing compartments, whereas trafficking of class II-peptide complexes to the membrane (and beyond) is less-well understood. Unlike other APCs, dendritic cells alter their capacity to present peptides via MHC class II molecules during differentiation, revealing a complex level of regulated antigen-presentation by this APC subtype.

Mesh:

Substances:

Year:  2002        PMID: 11790530     DOI: 10.1016/s0952-7915(01)00295-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  24 in total

1.  Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase.

Authors:  Pamela Stumptner-Cuvelette; Mabel Jouve; Julie Helft; Marc Dugast; Anne-Sophie Glouzman; Karin Jooss; Graça Raposo; Philippe Benaroch
Journal:  Mol Biol Cell       Date:  2003-09-17       Impact factor: 4.138

2.  Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.

Authors:  Yelena A Barabanova; Hee-Kap Kang; Jinjong Myoung; Bongsu Kang; Gail A Bishop; Byung S Kim
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

3.  HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

Authors:  Marcel van Lith; Rosanna M McEwen-Smith; Adam M Benham
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

4.  The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.

Authors:  Lynne S Arneson; Jim Miller
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

Review 5.  MHC class II transport at a glance.

Authors:  Adam C Berger; Paul A Roche
Journal:  J Cell Sci       Date:  2009-01-01       Impact factor: 5.285

6.  T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes.

Authors:  Aura Muntasell; Adam C Berger; Paul A Roche
Journal:  EMBO J       Date:  2007-09-06       Impact factor: 11.598

Review 7.  Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.

Authors:  Margaret L Axelrod; Rebecca S Cook; Douglas B Johnson; Justin M Balko
Journal:  Clin Cancer Res       Date:  2018-11-21       Impact factor: 12.531

8.  Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.

Authors:  Bret D Ulery; Yashdeep Phanse; Avanti Sinha; Michael J Wannemuehler; Balaji Narasimhan; Bryan H Bellaire
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

9.  Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Authors:  Kristen A Porter; Lauren N Kelley; Annette George; Jonathan A Harton; Karen M Duus
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

10.  Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.

Authors:  Ehud Hoze; Lea Tsaban; Yaakov Maman; Yoram Louzoun
Journal:  J Immunol Methods       Date:  2013-02-26       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.